BioSpace News Archive

Drug Development

Novo Nordisk: Xultophy Reported a Better Option Than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Participants in the DUAL VII Clinical Trial

These results were presented today at the 2017 International Diabetes Federation Congress in Abu Dhabi, UAE.

December 5, 2017

·

5 min read

Business

Oxford Genetics Announces Adeno-Associated Virus Collaboration With MeiraGTx

The collaboration will enable Oxford Genetics and MeiraGTx to develop novel AAV vectors, as well as packaging and producer cell lines.

December 5, 2017

·

2 min read

Business

Agios Appoints Jacqualyn Fouse, Ph.D., to the Board of Directors

Dr. Fouse previously served as president and chief operating officer of Celgene Corporation until April 2017.

December 5, 2017

·

3 min read

Genmab to Hold 2017 R&D Update

The meeting will include updates on daratumumab, including presentations by key opinion leaders on data from daratumumab studies presented at the 59th Annual Meeting of the American Society of Hematology (ASH).

December 5, 2017

·

4 min read

Drug Development

Novo Nordisk Receives FDA Approval of OZEMPIC (semaglutide) Injection for the Treatment of Adults With Type 2 Diabetes

The approval of OZEMPIC is based on the results from a Phase 3a clinical trial program.

December 5, 2017

·

8 min read

New Webinar From METTLER TOLEDO Shares How Weighing Accuracy Can be Protected

External factors that can influence weighing accuracy are often overlooked, even though an unreliable weighing result can have a profound effect downstream on the quality of the final result.

December 5, 2017

·

2 min read

Business

Plasticell and Anthony Nolan to Partner in Clinical Trials of Ex Vivo Expanded Cord Blood Stem Cells

The project is part of Plasticell’s hematopoietic cell therapy portfolio, which includes the expansion of hematopoietic stem cells and the manufacture of various blood cell types from pluripotent cell sources.

December 5, 2017

·

3 min read

Business

CluePoints Responds to Sponsor and CRO Demand with Two New Appointments

CluePoints, a leading provider of RBM and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team.

December 5, 2017

·

2 min read

BioForest

Kubota Pharmaceutical Holdings Co., Ltd. Announces Intention to Terminate SEC Reporting Obligations

The termination of the Company’s registration and reporting obligations under Section 13(a) and Section 15(d) of the Exchange Act is expected to be effective 90 days after filing of Form 15F.

December 5, 2017

·

3 min read

Business

LifeArc Appointments Strengthen Board of Trustees

LifeArc has strengthened its board by appointing three new trustees: Aisling Burnand, MBE, Chief Executive of the AMRC; Daniel Morgan; and Jessica Mann, Company Head, Cardiovascular Development Consulting, GmbH.

December 5, 2017

·

1 min read